Suzanne Ostrand-Rosenberg, Professor Emerita, has joined the BriaCell Scientific Advisor Board. BriaCell is a a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer and other cancers.
Dr. Sue Rosenberg joins BriaCell Scientific Advisory Board
|
November 5, 2021 at 10:58 AM
|